Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd

Bullboard Posts

Post by movingup1on Mar 24, 2013 9:31am

250 Views

Post# 21159852

The main dude is buying

Captain McInnes is still buying."F" me, what is he buying for.selling this lemon of a company maybe.In the meantime my drinking habit is getting me more and more in hot water.Just got out of jail again on last week.How in the "F" uck, did i know this prostitute was an undecover cop.I tried to explain, how can i pick up any broads with only 4.55 doolars to my name.The Pig did not buy it.Go BLV Go

Latest 10 SEDI filings (by transaction date) for BLV within the last 6 months	[?]
Amended Filing

					As of 11:59pm ET March 23rd, 2013
Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	# or value acquired or disposed of	Price
Mar 19/13	Mar 19/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	1,000	$0.005
Mar 18/13	Mar 18/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	22,000	$0.005
Mar 18/13	Mar 15/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	4,000	$0.005
Mar 15/13	Mar 14/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	10,000	$0.005
Mar 13/13	Mar 13/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	5,000	$0.005
Mar 13/13	Mar 12/13	McInnes, Donald Arthur	Direct Ownership	Common Shares	10 - Acquisition in the public market	97,000	$0.005
Mar 20/13	Mar 11/13	Douglas, David Mark	Direct Ownership	Common Shares	10 - Acquisition in the public market	500,000	$0.005
Mar 8/13	Mar 5/13	Douglas, David Mark	Direct Ownership	Common Shares	10 - Acquisition in the public market	88,000	$0.005
Feb 26/13	Feb 22/13	Douglas, David Mark	Direct Ownership	Common Shares	10 - Acquisition in the public market	10,000	$0.005
Feb 22/13	Feb 19/13	Douglas, David Mark	Direct Ownership	Common Shares	10 - Acquisition in the public market	7,000	$0.005